Patients with Dravet syndrome (DS) possess the majority of SCN1A variants identified to date, with variants detected in 70–80% of these patients (4, 5). This evidence concerns the gene SCN1A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.